Pomaglumetad

DB33616InvestigationalSmall molecule

Pomaglumetad: Overview.

Mechanism: Pharmacologically active on Metabotropic glutamate receptor 2 and Metabotropic glutamate receptor 3
Curator reviewed
Formula / weight: C₇H₉NO₆S · 235.21 g/mol (avg)
Code names: LY-404039

Resolves to

Compound

Structure

InChIKeyAVDUGNCTZRCAHH-MDASVERJSA-NSMILES[H][C@@]12[C@@H](C(O)=O)[C@]1([H])S(=O)(=O)C[C@@]2(N)C(O)=O

Targets

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pomaglumetad, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.